Deletion of UL34.5, therefore, suppresses T-VEC replication in non-tumor cells while simultaneously maintaining replication capacity in tumor cells due to the absence of PKR activity in most tumor cells (25). The gene discussed is EIF2AK2; the disease is neoplasm.